Neogen (NASDAQ:NEOG) Investors Are Sitting on a Loss of 58% If They Invested Three Years Ago
Neogen (NASDAQ:NEOG) Investors Are Sitting on a Loss of 58% If They Invested Three Years Ago
If you love investing in stocks you're bound to buy some losers. But long term Neogen Corporation (NASDAQ:NEOG) shareholders have had a particularly rough ride in the last three year. Regrettably, they have had to cope with a 58% drop in the share price over that period.
如果你喜欢投资股票,你一定会买入一些输家。但是,在过去三年中,Neogen Corporation(纳斯达克股票代码:NEOG)的长期股东经历了特别艰难的经历。遗憾的是,在此期间,他们不得不应对股价下跌58%的局面。
With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies.
考虑到这一点,值得一看公司的基本面是否是长期业绩的驱动力,或者是否存在一些差异。
While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).
虽然市场是一种强大的定价机制,但股价反映了投资者的情绪,而不仅仅是潜在的业务表现。研究市场情绪如何随着时间的推移而变化的一种方法是研究公司股价与其每股收益(EPS)之间的相互作用。
Neogen became profitable within the last five years. That would generally be considered a positive, so we are surprised to see the share price is down. So it's worth looking at other metrics to try to understand the share price move.
Neogen在过去五年中实现了盈利。这通常会被视为利好,因此我们惊讶地看到股价下跌。因此,值得研究其他指标来了解股价走势。
We note that, in three years, revenue has actually grown at a 28% annual rate, so that doesn't seem to be a reason to sell shares. It's probably worth investigating Neogen further; while we may be missing something on this analysis, there might also be an opportunity.
我们注意到,在三年内,收入实际上以28%的年增长率增长,因此这似乎不是出售股票的理由。可能值得进一步研究Neogen;虽然我们在分析中可能遗漏了一些东西,但也可能有机会。
The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).
下图描述了收入和收入随时间推移而发生的变化(点击图片即可显示确切的数值)。
We like that insiders have been buying shares in the last twelve months. Even so, future earnings will be far more important to whether current shareholders make money. If you are thinking of buying or selling Neogen stock, you should check out this free report showing analyst profit forecasts.
像我们一样,内部人士在过去的十二个月中一直在购买股票。即便如此,未来的收益对于当前股东是否赚钱将更为重要。如果您正在考虑买入或卖出Neogen股票,则应查看这份显示分析师利润预测的免费报告。
A Different Perspective
不同的视角
While the broader market gained around 26% in the last year, Neogen shareholders lost 9.6%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. However, the loss over the last year isn't as bad as the 8% per annum loss investors have suffered over the last half decade. We would want clear information suggesting the company will grow, before taking the view that the share price will stabilize. It's always interesting to track share price performance over the longer term. But to understand Neogen better, we need to consider many other factors. Case in point: We've spotted 1 warning sign for Neogen you should be aware of.
去年,整个市场上涨了约26%,而Neogen的股东却下跌了9.6%。但是,请记住,即使是最好的股票有时也会在十二个月内表现不如市场。但是,去年的亏损并不像投资者在过去五年中遭受的每年8%的亏损那么严重。在认为股价将稳定之前,我们希望获得明确的信息,表明该公司将增长。长期跟踪股价表现总是很有意思的。但是,为了更好地了解Neogen,我们需要考虑许多其他因素。一个很好的例子:我们已经发现了一个你应该注意的Neogen警告信号。
Neogen is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.
Neogen并不是内部人士唯一买入的股票。对于那些喜欢寻找获利投资的人来说,这份最近有内幕收购的成长型公司的免费清单可能就是入场券。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.
请注意,本文引用的市场回报反映了目前在美国交易所交易的股票的市场加权平均回报。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。